Argus Partners has acted for Eyestem Research Private Limited, a Bengaluru based cell therapy company in connection with its latest fund raising from Endiya Partners, a venture capital fund that focuses on investing in firms in technology, healthcare and life sciences. Eyecyte RPE, the company's patented flagship product, is close to finding a treatment for Dry AMD and the company …